Improved positron emission tomography imaging of glioblastoma cancer using novel

Improved positron emission tomography imaging of glioblastoma cancer using novel

Amino acids (2017-03-21)

Mathias Dyrberg Loft, Yao Sun, Changhao Liu, Camilla Christensen, Daijuan Huang, Andreas Kjaer, Zhen Cheng

RESUMEN

The urokinase-type plasminogen activator receptor (uPAR) is overexpressed in several cancers including glioblastoma (GBM) and is an established biomarker for metastatic potential. The uPAR-targeting peptide AE105-NH

MATERIALES

Referencia del producto

Marca

Descripción del producto

47998

Sigma-Aldrich

Fmoc-8-Aoc-OH, ≥98.0% (HPLC)